Save Stemcell Center ApS: Financial statements 2023
CVR: 39936119
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Save Stemcell Center ApS (CVR 39936119) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 335,479 and a net result of DKK 73,835 compared with DKK -139,052 the year before. That is an increase of 293.1% compared with the year before. Equity in the 2023 report amounted to DKK -582,707.
- Gross Profit
- DKK 335,479
- Profit/Loss
- DKK 73,835
- Equity
- DKK -582,707
- Total Assets
- DKK 176,724
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 335 t. | 74 t. | -583 t. | 0 |
| 2022 | - | 85 t. | -139 t. | -657 t. | 0 |
| 2021 | - | 542 t. | -429 t. | -517 t. | 1 |
| 2020 | - | 1.1 mio. | -205 t. | -89 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Save Stemcell Center ApS has published its annual report for 2022. Gross profit came to DKK 85,332, and the net result was DKK -139,052.
About Save Stemcell Center ApS
Save Stemcell Center ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Louise Camilla Zielinski. The company is owned by STORKEREDEN ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -25,469 and a net result of DKK -25,544 compared with DKK -158,178 the year before. Equity in the 2025 report amounted to DKK -766,429.